Cargando…

Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity

BACKGROUND: We herein report the first case of X-linked agammaglobulinemia (XLA) that underwent allogeneic stem cell transplantation using reduced intensity conditioning (RIC). We chronologically observed the reconstitution of humoral immunity in this case. CASE PRESENTATION: The patient was a 28-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikegame, Kazuhiro, Imai, Kohsuke, Yamashita, Motoi, Hoshino, Akihiro, Kanegane, Hirokazu, Morio, Tomohiro, Kaida, Katsuji, Inoue, Takayuki, Soma, Toshihiro, Tamaki, Hiroya, Okada, Masaya, Ogawa, Hiroyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752762/
https://www.ncbi.nlm.nih.gov/pubmed/26873735
http://dx.doi.org/10.1186/s13045-016-0240-y
_version_ 1782415785628532736
author Ikegame, Kazuhiro
Imai, Kohsuke
Yamashita, Motoi
Hoshino, Akihiro
Kanegane, Hirokazu
Morio, Tomohiro
Kaida, Katsuji
Inoue, Takayuki
Soma, Toshihiro
Tamaki, Hiroya
Okada, Masaya
Ogawa, Hiroyasu
author_facet Ikegame, Kazuhiro
Imai, Kohsuke
Yamashita, Motoi
Hoshino, Akihiro
Kanegane, Hirokazu
Morio, Tomohiro
Kaida, Katsuji
Inoue, Takayuki
Soma, Toshihiro
Tamaki, Hiroya
Okada, Masaya
Ogawa, Hiroyasu
author_sort Ikegame, Kazuhiro
collection PubMed
description BACKGROUND: We herein report the first case of X-linked agammaglobulinemia (XLA) that underwent allogeneic stem cell transplantation using reduced intensity conditioning (RIC). We chronologically observed the reconstitution of humoral immunity in this case. CASE PRESENTATION: The patient was a 28-year-old Japanese male with XLA who previously had life-threatening infectious episodes and was referred for the possible indication of allogeneic stem cell transplantation. After a thorough discussion within specialists from different backgrounds, we decided to perform allogeneic peripheral stem cell transplantation from his HLA-identical elder brother. Due to the non-malignant nature of XLA, we selected RIC consisting of fludarabine, cyclophosphamide, anti-thymocyte globulin, and 3 Gy of total body irradiation. Neutrophil engraftment was achieved on day 11 with complete donor chimerism. No major complications, except for stage 1 skin graft-versus-host disease, were observed. The patient was discharged on day 75 and has been followed as an outpatient without any infectious episodes for more than 500 days. CONCLUSIONS: Regarding immune reconstitution, CD19(+) cells, IgA, and IgM, which were undetectable before allogeneic stem cell transplantation (allo-SCT), started to increase in number 10 days after allo-SCT and continued to increase for more than 1 year. Anti-B antibodies appeared as early as day 10. Total IgG levels decreased after the discontinuation of IgG replacement and spontaneously recovered after day 350. However, most anti-viral IgG titers, except EB virus-virus capsid antigen IgG, disappeared after the discontinuation of IgG replacement. A seasonal vaccination to influenza was performed on day 148, with neither anti-influenza type A nor type B being positive after the vaccination. The transient transfer of allergic immunity to orchard grass was observed. Similar Bruton’s tyrosine kinase (BTK) expression levels in monocytes and B-cells were observed between the patient and healthy control. B-cells in the peripheral blood (PB) of the patient on day 279 showed sufficient proliferation after a CD40L and IL-21 or CD40L and CpG stimulation. Effective immunoglobulin production and class switching were also observed after a CD40L and IL-21 or CpG stimulation. Signal joint kappa-deleting recombination excision circles (sjKRECs) became positive 16 days post-SCT, increased to 6300 copies/μg DNA at 42 days, and were maintained at a high level thereafter. The recovery of T-cell receptor excision circles (TRECs) was slow, but became detectable 1 year post-hematopoietic stem cell transplantation (HSCT).
format Online
Article
Text
id pubmed-4752762
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47527622016-02-14 Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity Ikegame, Kazuhiro Imai, Kohsuke Yamashita, Motoi Hoshino, Akihiro Kanegane, Hirokazu Morio, Tomohiro Kaida, Katsuji Inoue, Takayuki Soma, Toshihiro Tamaki, Hiroya Okada, Masaya Ogawa, Hiroyasu J Hematol Oncol Case Report BACKGROUND: We herein report the first case of X-linked agammaglobulinemia (XLA) that underwent allogeneic stem cell transplantation using reduced intensity conditioning (RIC). We chronologically observed the reconstitution of humoral immunity in this case. CASE PRESENTATION: The patient was a 28-year-old Japanese male with XLA who previously had life-threatening infectious episodes and was referred for the possible indication of allogeneic stem cell transplantation. After a thorough discussion within specialists from different backgrounds, we decided to perform allogeneic peripheral stem cell transplantation from his HLA-identical elder brother. Due to the non-malignant nature of XLA, we selected RIC consisting of fludarabine, cyclophosphamide, anti-thymocyte globulin, and 3 Gy of total body irradiation. Neutrophil engraftment was achieved on day 11 with complete donor chimerism. No major complications, except for stage 1 skin graft-versus-host disease, were observed. The patient was discharged on day 75 and has been followed as an outpatient without any infectious episodes for more than 500 days. CONCLUSIONS: Regarding immune reconstitution, CD19(+) cells, IgA, and IgM, which were undetectable before allogeneic stem cell transplantation (allo-SCT), started to increase in number 10 days after allo-SCT and continued to increase for more than 1 year. Anti-B antibodies appeared as early as day 10. Total IgG levels decreased after the discontinuation of IgG replacement and spontaneously recovered after day 350. However, most anti-viral IgG titers, except EB virus-virus capsid antigen IgG, disappeared after the discontinuation of IgG replacement. A seasonal vaccination to influenza was performed on day 148, with neither anti-influenza type A nor type B being positive after the vaccination. The transient transfer of allergic immunity to orchard grass was observed. Similar Bruton’s tyrosine kinase (BTK) expression levels in monocytes and B-cells were observed between the patient and healthy control. B-cells in the peripheral blood (PB) of the patient on day 279 showed sufficient proliferation after a CD40L and IL-21 or CD40L and CpG stimulation. Effective immunoglobulin production and class switching were also observed after a CD40L and IL-21 or CpG stimulation. Signal joint kappa-deleting recombination excision circles (sjKRECs) became positive 16 days post-SCT, increased to 6300 copies/μg DNA at 42 days, and were maintained at a high level thereafter. The recovery of T-cell receptor excision circles (TRECs) was slow, but became detectable 1 year post-hematopoietic stem cell transplantation (HSCT). BioMed Central 2016-02-13 /pmc/articles/PMC4752762/ /pubmed/26873735 http://dx.doi.org/10.1186/s13045-016-0240-y Text en © Ikegame et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Ikegame, Kazuhiro
Imai, Kohsuke
Yamashita, Motoi
Hoshino, Akihiro
Kanegane, Hirokazu
Morio, Tomohiro
Kaida, Katsuji
Inoue, Takayuki
Soma, Toshihiro
Tamaki, Hiroya
Okada, Masaya
Ogawa, Hiroyasu
Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title_full Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title_fullStr Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title_full_unstemmed Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title_short Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
title_sort allogeneic stem cell transplantation for x-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752762/
https://www.ncbi.nlm.nih.gov/pubmed/26873735
http://dx.doi.org/10.1186/s13045-016-0240-y
work_keys_str_mv AT ikegamekazuhiro allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT imaikohsuke allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT yamashitamotoi allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT hoshinoakihiro allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT kaneganehirokazu allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT moriotomohiro allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT kaidakatsuji allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT inouetakayuki allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT somatoshihiro allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT tamakihiroya allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT okadamasaya allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity
AT ogawahiroyasu allogeneicstemcelltransplantationforxlinkedagammaglobulinemiausingreducedintensityconditioningasamodelofthereconstitutionofhumoralimmunity